GRANULES INDIA
Quarterly Results Analysis [Sep2024]
GRANULES INDIA Quarterly Results
Consolidated | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹967 Cr | ₹1,180 Cr | ₹1,176 Cr | ₹1,156 Cr | ₹1,189 Cr | ₹986 Cr | ₹1,196 Cr | ₹1,146 Cr |
Expenses | ₹763 Cr | ₹921 Cr | ₹920 Cr | ₹905 Cr | ₹977 Cr | ₹849 Cr | ₹967 Cr | ₹915 Cr |
Operating Income | ₹203 Cr | ₹259 Cr | ₹256 Cr | ₹250 Cr | ₹213 Cr | ₹137 Cr | ₹228 Cr | ₹231 Cr |
Other Income | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹3 Cr | ₹1 Cr |
Interest | ₹26 Cr | ₹27 Cr | ₹29 Cr | ₹29 Cr | ₹26 Cr | ₹22 Cr | ₹19 Cr | ₹17 Cr |
Depreciation | ₹53 Cr | ₹53 Cr | ₹53 Cr | ₹52 Cr | ₹53 Cr | ₹49 Cr | ₹49 Cr | ₹48 Cr |
Profit Before Tax | ₹128 Cr | ₹181 Cr | ₹176 Cr | ₹170 Cr | ₹136 Cr | ₹65 Cr | ₹164 Cr | ₹167 Cr |
Profit After Tax | ₹97 Cr | ₹135 Cr | ₹130 Cr | ₹126 Cr | ₹102 Cr | ₹48 Cr | ₹120 Cr | ₹124 Cr |
EPS | ₹4.01 | ₹5.56 | ₹5.35 | ₹5.18 | ₹4.21 | ₹1.98 | ₹4.94 | ₹5.14 |
Industry Peers & Returns | 1W | 1M | 1Y |
GRANULES INDIA | -1.2% | -0.5% | 55.7% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
CIPLA | -1.1% | -0.3% | 20.7% |
DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
LUPIN | 0.9% | 7.2% | 72.7% |
GRANULES INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -18.07 % |
Y-o-Y | -18.74 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹967 Cr | -18.07 | |
Jun2024 | ₹1,180 Cr | 0.35 | |
Mar2024 | ₹1,176 Cr | 1.75 | |
Dec2023 | ₹1,156 Cr | -2.85 | |
Sep2023 | ₹1,189 Cr | 20.70 | |
Jun2023 | ₹986 Cr | -17.56 | |
Mar2023 | ₹1,196 Cr | 4.31 | |
Dec2022 | ₹1,146 Cr | - |
GRANULES INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -21.58 % |
Y-o-Y | -4.53 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹203 Cr | -21.58 | |
Jun2024 | ₹259 Cr | 1.39 | |
Mar2024 | ₹256 Cr | 2.09 | |
Dec2023 | ₹250 Cr | 17.61 | |
Sep2023 | ₹213 Cr | 55.66 | |
Jun2023 | ₹137 Cr | -40.02 | |
Mar2023 | ₹228 Cr | -1.37 | |
Dec2022 | ₹231 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -4.28 % |
Y-o-Y | 17.49 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 21.03% | -4.28 | |
Jun2024 | 21.97% | 1.01 | |
Mar2024 | 21.75% | 0.32 | |
Dec2023 | 21.68% | 21.12 | |
Sep2023 | 17.9% | 28.96 | |
Jun2023 | 13.88% | -27.25 | |
Mar2023 | 19.08% | -5.45 | |
Dec2022 | 20.18% | - |
GRANULES INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -27.79 % |
Y-o-Y | -4.78 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹97 Cr | -27.79 | |
Jun2024 | ₹135 Cr | 3.86 | |
Mar2024 | ₹130 Cr | 3.18 | |
Dec2023 | ₹126 Cr | 23.05 | |
Sep2023 | ₹102 Cr | 113.21 | |
Jun2023 | ₹48 Cr | -59.96 | |
Mar2023 | ₹120 Cr | -3.80 | |
Dec2022 | ₹124 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -11.83 % |
Y-o-Y | 17.25 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 10.06 % | -11.83 | |
Jun2024 | 11.41 % | 3.45 | |
Mar2024 | 11.03 % | 1.47 | |
Dec2023 | 10.87 % | 26.69 | |
Sep2023 | 8.58 % | 76.54 | |
Jun2023 | 4.86 % | -51.40 | |
Mar2023 | 10 % | -7.83 | |
Dec2022 | 10.85 % | - |
GRANULES INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -27.88 % |
Y-o-Y | -4.75 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹4.01 | -27.88 | |
Jun2024 | ₹5.56 | 3.93 | |
Mar2024 | ₹5.35 | 3.28 | |
Dec2023 | ₹5.18 | 23.04 | |
Sep2023 | ₹4.21 | 112.63 | |
Jun2023 | ₹1.98 | -59.92 | |
Mar2023 | ₹4.94 | -3.89 | |
Dec2022 | ₹5.14 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD